Elevated emotion reactivity and emotion regulation in individuals at clinical high risk for developing psychosis and those diagnosed with a psychotic disorder.
affective
negative symptoms
prodromal
schizophrenia-spectrum
social functioning
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
29
06
2021
received:
25
01
2021
accepted:
15
08
2021
pubmed:
17
9
2021
medline:
7
7
2022
entrez:
16
9
2021
Statut:
ppublish
Résumé
Disrupted affective processes are core features of psychosis; yet emotion reactivity and emotion regulation impairments have not been fully characterized in individuals at clinical high-risk for developing psychosis (CHR) or adolescents diagnosed with a psychotic disorder (AOP). Characterizing these impairments may provide a fuller understanding of factors contributing to psychosis risk and psychosis onset. Using cross-sectional and longitudinal data, we evaluated (1) group-level effects of emotion reactivity and regulation, (2) stability of group-level effects over time and age, (3) relationships between emotion reactivity and regulation, and (4) associations between these measures and psychosocial functioning and clinical symptomatology. Eighty-seven participants (CHR = 32, TD = 42, AOP = 13; 12-25 years, 1-5 visits) completed the Emotion Reactivity Scale, Difficulties in Emotion Regulation Scale, and Emotion Regulation Questionnaire. We assessed psychotic symptoms with the Structured Interview for Prodromal Syndromes and measured real-world functioning with the Global Functioning: Social and Role Scales. We used analysis of variance to assess Aim 1 and linear mixed models to address Aims 2-4. CHR and AOP endorsed experiencing heightened levels of emotion reactivity and greater difficulty utilizing emotion regulation strategies compared to TD. These impairments were stable across time and adolescent development. Greater levels of emotion reactivity were associated with greater emotion regulation impairments. Greater impairments in emotion regulation were associated with lower social functioning and greater negative symptom severity. Therapeutic interventions designed to reduce emotion reactivity and improve one's ability to utilize emotion regulation strategies may be effective in reducing clinical symptomatology and improving real-world functioning in CHR and AOP.
Identifiants
pubmed: 34528404
doi: 10.1111/eip.13212
pmc: PMC10282844
mid: NIHMS1905970
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
724-735Subventions
Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH097040
Pays : United States
Informations de copyright
© 2021 John Wiley & Sons Australia, Ltd.
Références
J R Soc Med. 2012 Mar;105(3):111-6
pubmed: 22434810
Neuroimage Clin. 2014 Aug 20;6:43-53
pubmed: 25379415
Hum Brain Mapp. 2019 Nov 1;40(16):4703-4715
pubmed: 31322784
J Cogn Neurosci. 2008 Sep;20(9):1565-82
pubmed: 18345988
J Consult Clin Psychol. 1978 Oct;46(5):947-52
pubmed: 701573
Schizophr Res. 2008 Feb;99(1-3):119-24
pubmed: 18023329
Biol Psychiatry. 2021 Jan 15;89(2):194-204
pubmed: 33268030
J Psychiatr Res. 2015 Sep;68:254-60
pubmed: 26228427
J Psychiatr Res. 2018 Jan;96:239-246
pubmed: 29126059
Schizophr Res. 2014 Mar;153(1-3):25-31
pubmed: 24552619
J Pers Soc Psychol. 1998 Jan;74(1):224-37
pubmed: 9457784
Schizophr Bull. 2007 May;33(3):688-702
pubmed: 17440198
Clin Psychol Rev. 2008 Apr;28(4):676-91
pubmed: 18006196
J Child Adolesc Psychopharmacol. 2005 Jun;15(3):434-51
pubmed: 16092909
Mol Psychiatry. 2008 Sep;13(9):829, 833-57
pubmed: 18574483
J Cogn Neurosci. 2002 Nov 15;14(8):1215-29
pubmed: 12495527
Psychiatry Res. 2011 Feb 28;185(3):303-8
pubmed: 20678808
Schizophr Res. 2010 May;118(1-3):88-97
pubmed: 20188516
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Neurosci Biobehav Rev. 2014 Sep;45:202-11
pubmed: 24984244
Clin Psychol Rev. 2007 May;27(4):409-24
pubmed: 17222489
Cogn Emot. 2011 Apr;25(3):400-12
pubmed: 21432682
Neuroimage. 2014 Feb 15;87:345-55
pubmed: 24220041
Acta Psychiatr Scand. 2006 Sep;114(3):177-86
pubmed: 16889588
Am J Psychiatry. 2019 Dec 1;176(12):1021-1029
pubmed: 31509006
Arch Gen Psychiatry. 2001 Dec;58(12):1137-44
pubmed: 11735842
Clin Psychol (New York). 2010 Dec 1;17(4):307-318
pubmed: 21442035
Monogr Soc Res Child Dev. 1994;59(2-3):25-52
pubmed: 7984164
JAMA Psychiatry. 2016 Dec 01;73(12):1239-1248
pubmed: 27806157
Psychol Med. 2016 Oct;46(14):2907-2918
pubmed: 27050714
Biol Psychiatry. 2005 Mar 15;57(6):624-32
pubmed: 15780849
Nat Rev Neurosci. 2008 Apr;9(4):267-77
pubmed: 18354399
Cognit Ther Res. 2016 Jun;40(3):394-415
pubmed: 27695145
Schizophr Res. 2012 Jan;134(1):1-9
pubmed: 22056201
Addiction. 2017 Apr;112(4):695-704
pubmed: 27896905
Dev Psychopathol. 2020 Feb;32(1):219-227
pubmed: 30739633
Psychol Med. 2015 Oct;45(14):2959-73
pubmed: 26040537
J Stud Alcohol Drugs. 2013 Jul;74(4):576-83
pubmed: 23739021
Psychiatry Res. 2012 Dec 30;200(2-3):193-201
pubmed: 22749227
Schizophr Res. 2018 Mar;193:428-434
pubmed: 28811079
Psychol Med. 2013 Feb;43(2):259-68
pubmed: 22651857
NPJ Schizophr. 2020 Mar 24;6(1):7
pubmed: 32210232
Depress Anxiety. 2010 Dec;27(12):1087-94
pubmed: 21132844
J Affect Disord. 2018 Jan 1;225:474-481
pubmed: 28863300
Biol Psychiatry. 2011 Dec 15;70(12):1159-68
pubmed: 21861986
Biol Psychiatry. 2012 Jan 15;71(2):136-45
pubmed: 21993193
Am J Psychiatry. 2019 Mar 1;176(3):196-207
pubmed: 30654642
J Abnorm Psychol. 2011 Feb;120(1):155-67
pubmed: 21319928
Schizophr Bull. 2018 Jun 6;44(4):757-767
pubmed: 29878274
Dev Psychopathol. 2019 Aug;31(3):899-915
pubmed: 30957738
Neuroimage. 2012 Sep;62(3):1575-81
pubmed: 22634856
Psychophysiology. 2003 Sep;40(5):655-65
pubmed: 14696720
J Psychiatry Neurosci. 2009 Nov;34(6):418-32
pubmed: 19949718
Bipolar Disord. 2018 Jun;20(4):349-358
pubmed: 29430790
Hum Brain Mapp. 2010 Jun;31(6):926-33
pubmed: 20496383
J Child Psychol Psychiatry. 2010 May;51(5):567-74
pubmed: 19845818
Schizophr Bull. 2016 May;42(3):712-22
pubmed: 26834027
Am J Psychiatry. 1993 Nov;150(11):1654-60
pubmed: 8214173
Biol Psychiatry. 2009 Dec 1;66(11):1023-30
pubmed: 19733837
J Abnorm Psychol. 2008 May;117(2):473-478
pubmed: 18489225
Biol Psychiatry. 2013 Mar 15;73(6):565-73
pubmed: 22980587
Schizophr Res. 2014 Dec;160(1-3):136-41
pubmed: 25468184
J Pers Soc Psychol. 2003 Aug;85(2):348-62
pubmed: 12916575
Schizophr Res. 2016 Mar;171(1-3):176-81
pubmed: 26785807
Br J Clin Psychol. 2011 Jun;50(2):217-22
pubmed: 21545453
Arch Gen Psychiatry. 2010 Jun;67(6):578-88
pubmed: 20530007
Addict Behav. 2008 Feb;33(2):388-94
pubmed: 18023295
Neuron. 2011 Mar 10;69(5):1029-36
pubmed: 21382560
Monogr Soc Res Child Dev. 1994;59(2-3):167-86
pubmed: 7984159
J Affect Disord. 2017 Mar 15;211:144-149
pubmed: 28113121
Behav Ther. 2008 Jun;39(2):107-16
pubmed: 18502244
Schizophr Bull. 2014 Mar;40(2):469-77
pubmed: 23599250
Schizophr Res. 2011 Aug;130(1-3):170-5
pubmed: 21620681
Schizophr Bull. 2016 Nov;42(6):1353-1362
pubmed: 27109925
PLoS One. 2016 Nov 30;11(11):e0167360
pubmed: 27902751
Pers Individ Dif. 2016 Nov;102:123-132
pubmed: 31507307
J Pers Soc Psychol. 1990 Mar;58(3):487-98
pubmed: 2182826
J Anxiety Disord. 2014 May;28(4):394-401
pubmed: 24726241
Schizophr Bull. 2021 Jan 23;47(1):87-96
pubmed: 32609340